risks of glp-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution – The Chicago Council on Science and Technology GLP-1 Agonists: Using Semaglutide, Tirzepatide,

98.8% of customers buy 6 or more items

Two key genes TCF7L2 and GLP1R affect how well your GLP-1 system works

Currently, there are multiple lawsuits against the pharma giants for alleged inadequate or under- reporting of side effects associated with GLP-1 medications like Mounjaro and Ozempic, resulting in numerous hospitalizations and surgeries

Safety Considerations Most common adverse effects: Nausea Vomiting Diarrhea GI intolerance Rare but important: Pancreatitis Gallbladder disease Potential thyroid C-cell concerns in animal models Careful patient selection and dose titration remain essential

H., Salem, V

However, the FDA has received voluntary reports from patients describing emotional numbness, reduced motivation, and depressive symptoms after starting GLP-1 therapy, though causality remains unclear